Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tumour development actors ERK1 and ERK2 found to play opposite roles

28.06.2006
The proteins ERK1 and ERK2 may play opposite roles during tumour development. A study published today in the open access journal Journal of Biology shows that the phosphorylating enzyme, or ‘kinase’, ERK1 can inhibit cell proliferation by interfering with the action of the related kinase ERK2. ERK1 and ERK2 are crucial components of the signalling cascade that mediates the function of the Ras oncogenes, an important class of oncogenes involved in the development of many human cancers.

In the absence of ERK1, ERK2 shows increased activity and it promotes both normal and Ras-dependent cell proliferation. In contrast, increased levels of ERK1 in cells significantly slow down their proliferation rate, especially when Ras oncoproteins are activated. These findings disprove the assumption that ERK1 and ERK2 have the same function and are fully interchangeable. This suggests that the mechanism controlling cell proliferation and malignancy is more complex than previously thought.

Chiara Vantaggiato, Ivan Formentini and colleagues in Riccardo Brambilla’s group, from the San Raffaele Scientific Institute in Milan, Italy, used gene targeting and RNA interference (RNAi) techniques to inhibit the MAP kinases ERK1 and ERK2 in mouse cells. Their results show that inhibiting ERK1 enhances ERK2 activity and promotes cell proliferation. In contrast, the knockdown of ERK2 almost completely abolishes cell proliferation. Mouse tumour cells expressing ERK1, but not ERK2, to higher levels than normally seen in tumour cells, grow into very small tumours when transplanted into live mice. Cells expressing only the protein Ras grow into much larger tumours and overexpressing ERK2 doesn’t affect the size of the tumours.

The authors propose that ERK1 and ERK2 are in competition to bind to other regulatory molecules in the signalling pathway. Their activities and expression levels must be finely tuned to ensure normal cell proliferation.

Juliette Savin | alfa
Further information:
http://www.biomedcentral.com

More articles from Life Sciences:

nachricht During HIV infection, antibody can block B cells from fighting pathogens
14.08.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht First study on physical properties of giant cancer cells may inform new treatments
14.08.2018 | Brown University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

Im Focus: World record: Fastest 3-D tomographic images at BESSY II

The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.

Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

'Building up' stretchable electronics to be as multipurpose as your smartphone

14.08.2018 | Information Technology

During HIV infection, antibody can block B cells from fighting pathogens

14.08.2018 | Life Sciences

First study on physical properties of giant cancer cells may inform new treatments

14.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>